23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1317.28%
Revenue growth exceeding 1.5x Insurance - Life median of 0.36%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
1317.28%
Gross profit growth exceeding 1.5x Insurance - Life median of 0.56%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
236.28%
EBIT growth exceeding 1.5x Insurance - Life median of 11.27%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
236.28%
Operating income growth exceeding 1.5x Insurance - Life median of 14.16%. Joel Greenblatt would see if unique processes drive exceptional profitability.
235.66%
Net income growth exceeding 1.5x Insurance - Life median of 10.41%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
235.63%
EPS growth exceeding 1.5x Insurance - Life median of 10.53%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
235.65%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 10.53%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
46.44%
OCF growth exceeding 1.5x Insurance - Life median of 25.60%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.
46.44%
FCF growth 1.25-1.5x Insurance - Life median of 40.39%. Mohnish Pabrai might attribute it to efficient operations or capital spending.
134.86%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 64.81%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
25.00%
5Y revenue/share growth 50-75% of Insurance - Life median of 38.86%. Guy Spier might worry about slower mid-term expansions vs. peers.
90.77%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 18.08%. Joel Greenblatt might see a short-term competitive advantage at play.
111.12%
OCF/share CAGR of 111.12% while Insurance - Life median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
33.57%
OCF/share CAGR of 33.57% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
14.86%
3Y OCF/share growth of 14.86% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
429.12%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 126.25% over a decade. Joel Greenblatt might see a standout compounder of earnings.
277.07%
5Y net income/share CAGR > 1.5x Insurance - Life median of 103.13%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
112.60%
3Y net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm expansions or margin boosts drive the short-term advantage.
112.03%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 73.08% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
26.13%
5Y equity/share CAGR near Insurance - Life median. Charlie Munger finds it normal mid-term expansion for the industry.
18.85%
Below 50% of Insurance - Life median. Jim Chanos worries about inadequate short-term profitability or repeated asset impairments.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.10%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
2.34%
Asset growth 1.25-1.5x Insurance - Life median. Mohnish Pabrai sees if expansions are strategic and well-supported by end demand.
4.35%
Near Insurance - Life median. Charlie Munger considers it standard net worth compounding for the sector.
-13.42%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-6.89%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.